Skip to content
London Wheel Today

Patients Coming Off Weight-Loss Injections Put On Pounds Four Times Faster Compared to Dieters

Illustration of pharmaceutical injection and scale
Weight management involves long-term strategies.

A recent study suggests that people who discontinue blockbuster GLP-1 drugs like Wegovy and Mounjaro can put back on lost weight far faster than those who halt traditional lifestyle plans.

Published data in a prominent medical journal points out that while obese individuals can lose substantial amounts of their body weight while on the medication, the mass returns at an average rate of nearly a kilo each month after stopping.

"Individuals using these drugs need to be informed of the potential of quick rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.

Such speed of recovery implies a return to original weight within about one and a half years.

Analyzing Therapies

The study, which examined dozens of trials involving thousands of participants, compared the results of GLP-1 agonists with other pills.

The team emphasize that people who lose weight through diet and exercise usually see a more gradual creep back—approximately 0.1 kg a month—post-intervention.

Understanding the Quick Rebound

Experts propose the mode of action of the injections accounts for the heightened rebound.

These medications copy a natural hormone called GLP-1, which controls appetite.

"Sustained high doses of the hormone concentrations far above than the body's typical production might result in the system to produce less of its own natural hormone, and could lessen sensitivity to its actions," noted Dr. Adam Collins, a dietetics expert.

"Stopping of this GLP-1 'fix' means appetite is no longer kept in check, making binge eating much more probable."

An Ongoing Condition?

Medical guidelines advise the injections for people with weight-linked medical conditions, alongside recommended diet and exercise modifications.

Many experts contend that, given the significant potential of weight regain, the treatment should be considered life-long.

This perspective is echoed by drug manufacturers, who say that the results "underscore the chronic nature of excess weight," similar to managing conditions like high blood pressure.

Patient Experiences

Users who have come off the medication report a powerful resurgence of appetite.

"It felt as if a switch that goes on and you become ravenous," said a patient.

This challenge is compounded if patients have not adopted sustainable dietary or behavioural modifications during therapy.

Significant Adoption

Recent estimates suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with demand being substantial.

  • Adoption is more common among females compared to males.
  • The 40s and 50s age group shows the highest usage rates.
  • A large proportion access the medications through private prescriptions rather than public health services.

Finally, clinicians stress that while GLP-1 drugs are effective agents for weight loss, they are not a standalone solution and lasting health benefits likely depends on combined lifestyle changes.

About the author

Robert Hoffman

Eleanor is a travel writer based in London, sharing insider tips on the city's top attractions.

London Wheel Today

Type to search articles.